5.0
Mar 21, 2022
Current employee, less than 1 year
Recommend
CEO approval
Business Outlook
Pros
Global very innovative player that has developed a breakthrough cell-free DNA and cell-free RNA liquid biopsy based technology that helps better treatment (personalized) of patients in onclogy as well as in infectious diseases. High level of respect for all coworkers, supplier and customers. Open and honest communication and transparency are given.
Cons
Sometimes teleconferences are too late at night, however that takes the various time zones globally into account.